Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 114.57%920.14M | 430.82%428.84M | 62,009.26%80.79M | 246.86%130.07K | -40.00%37.5K | 2,572.31%62.5K | -100.53%-2.53K | -89.58%473.12K | 4.54M | |
| Revenue from customers | 114.50%918.67M | 432.87%428.29M | --80.37M | ---- | ---- | ---- | ---- | -88.83%1.22M | --10.9M | ---- |
| Other cash income from operating activities | 167.09%1.47M | 32.85%550K | 218.28%414K | 246.86%130.07K | -40.00%37.5K | 2,572.31%62.5K | 99.66%-2.53K | 88.30%-743.99K | ---6.36M | ---- |
| Cash paid | -70.61%-505.05M | -145.14%-296.02M | -609.98%-120.76M | -20.97%-17.01M | -65.83%-14.06M | -15.67%-8.48M | -66.95%-7.33M | -52.18%-4.39M | -56.22%-2.89M | -20.98%-1.85M |
| Payments to suppliers for goods and services | -79.31%-505.05M | -203.99%-281.66M | -2,574.59%-92.65M | -118.08%-3.46M | -32.61%-1.59M | -11.41%-1.2M | -18.48%-1.08M | 24.89%-907.53K | -81.12%-1.21M | -150.72%-667.08K |
| Other cash payments from operating activities | ---- | 48.88%-14.37M | -107.49%-28.1M | -8.60%-13.54M | -71.30%-12.47M | -16.41%-7.28M | -79.57%-6.25M | -107.70%-3.48M | -42.15%-1.68M | 6.41%-1.18M |
| Direct interest paid | -53.11%-4.33M | -5,560.00%-2.83M | ---50K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Direct interest received | 58.96%9.95M | 156.31%6.26M | 7,300.67%2.44M | 48.91%33K | 140.54%22.16K | -87.98%9.21K | 77.90%76.64K | 58.60%43.08K | 318.75%27.16K | 79.42%6.49K |
| Operating cash flow | 208.79%420.71M | 462.58%136.24M | -123.06%-37.58M | -20.32%-16.85M | -66.53%-14M | -15.87%-8.41M | -87.28%-7.26M | -330.38%-3.87M | 191.38%1.68M | -20.84%-1.84M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -150.03%-442.69M | 50.86%-177.06M | -33,645.08%-360.3M | 90.21%-1.07M | -53,796.42%-10.91M | -20.24K | -100.88%-950 | 1,958.18%108.2K | -2,980.95%-5.82K | |
| Capital expenditure reported | 33.42%-15M | -398.65%-22.53M | -415.23%-4.52M | 91.76%-877.09K | ---10.64M | ---- | ---- | ---- | ---- | ---- |
| Net PPE purchase and sale | -19.53%-167.96M | -2,948.62%-140.51M | -2,317.71%-4.61M | 28.63%-190.64K | -1,219.77%-267.11K | ---20.24K | ---- | 79.84%-950 | 19.06%-4.71K | -2,980.95%-5.82K |
| Net business purchase and sale | ---249.99M | ---- | ---371.66M | ---- | ---- | ---- | ---- | ---- | --112.92K | ---- |
| Net investment purchase and sale | -6,398.67%-9.75M | ---150K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net other investing changes | ---- | -167.69%-13.86M | --20.48M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -150.03%-442.69M | 50.86%-177.06M | -33,645.08%-360.3M | 90.21%-1.07M | -53,796.42%-10.91M | ---20.24K | ---- | -100.88%-950 | 1,958.18%108.2K | -2,980.95%-5.82K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 195.17%90.23M | -94.57%30.57M | 2,342.13%563.3M | -6.73%23.07M | 45.79%24.73M | 256.30%16.96M | -1.32%4.76M | 191.84%4.82M | -32.68%1.65M | 343.54%2.46M |
| Net issuance payments of debt | 320.27%102.54M | 12,299.50%24.4M | ---200K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net common stock issuance | -84.03%1.69M | -98.13%10.6M | 2,352.75%565.75M | -6.73%23.07M | 45.79%24.73M | 256.30%16.96M | -1.32%4.76M | 191.84%4.82M | -32.68%1.65M | 343.54%2.46M |
| Net other financing activities | -58.12%-14M | -97.15%-8.86M | ---4.49M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 195.17%90.23M | -94.57%30.57M | 2,342.13%563.3M | -6.73%23.07M | 45.79%24.73M | 256.30%16.96M | -1.32%4.76M | 191.84%4.82M | -32.68%1.65M | 343.54%2.46M |
| Net cash flow | ||||||||||
| Beginning cash position | -5.65%171.29M | 1,026.24%181.54M | 46.99%16.12M | -1.61%10.97M | 327.05%11.15M | -48.88%2.61M | 22.84%5.1M | 483.66%4.16M | 542.42%711.99K | -91.06%110.83K |
| Current changes in cash | 765.91%68.24M | -106.20%-10.25M | 3,110.30%165.42M | 2,974.54%5.15M | -102.10%-179.26K | 442.10%8.54M | -362.83%-2.5M | -72.43%949.31K | 464.89%3.44M | 162.87%609.52K |
| Effect of exchange rate changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 105.60%468 | 94.76%-8.36K |
| End cash Position | 39.84%239.53M | -5.65%171.29M | 1,026.24%181.54M | 46.99%16.12M | -1.61%10.97M | 327.05%11.15M | -48.88%2.61M | 22.84%5.1M | 483.66%4.16M | 542.42%711.99K |
| Free cash from | 939.35%237.65M | 39.39%-28.31M | -160.78%-46.71M | 28.09%-17.91M | -195.57%-24.91M | -16.15%-8.43M | -87.23%-7.26M | -331.09%-3.88M | 190.84%1.68M | -21.20%-1.85M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |